The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Blend Labs Inc (NYSE: BLND) closed at $3.52 in the last session, down -1.95% from day before closing price of $3.59. In other words, the price has decreased by -$1.95 from its previous closing price. On the day, 3.98 million shares were traded. BLND stock price reached its highest trading level at $3.64 during the session, while it also had its lowest trading level at $3.46.
Ratios:
We take a closer look at BLND’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.44 and its Current Ratio is at 3.44.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on December 18, 2024, initiated with a Mkt Outperform rating and assigned the stock a target price of $7.
On August 12, 2024, Canaccord Genuity Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $3 to $4.75.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 10 ’25 when Haveli Investments, L.P. bought 1,062,317 shares for $3.09 per share. The transaction valued at 3,281,285 led to the insider holds 3,123,242 shares of the business.
Haveli Investments, L.P. bought 1,416,037 shares of BLND for $4,320,754 on Mar 07 ’25. The Director now owns 2,060,925 shares after completing the transaction at $3.05 per share. On Mar 06 ’25, another insider, Haveli Investments, L.P., who serves as the Director of the company, bought 587,149 shares for $3.05 each. As a result, the insider paid 1,790,863 and bolstered with 644,888 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BLND now has a Market Capitalization of 914010240 and an Enterprise Value of 1031580352. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.64. Its current Enterprise Value per Revenue stands at 6.367 whereas that against EBITDA is -25.559.
Stock Price History:
The Beta on a monthly basis for BLND is 1.30, which has changed by 0.17333329 over the last 52 weeks, in comparison to a change of 0.101756096 over the same period for the S&P500. Over the past 52 weeks, BLND has reached a high of $5.53, while it has fallen to a 52-week low of $2.08. The 50-Day Moving Average of the stock is -3.07%, while the 200-Day Moving Average is calculated to be -4.32%.
Shares Statistics:
According to the various share statistics, BLND traded on average about 3.44M shares per day over the past 3-months and 3163500 shares per day over the past 10 days. A total of 254.43M shares are outstanding, with a floating share count of 204.96M. Insiders hold about 21.07% of the company’s shares, while institutions hold 50.98% stake in the company. Shares short for BLND as of 1741910400 were 9273106 with a Short Ratio of 2.70, compared to 1739491200 on 8600104. Therefore, it implies a Short% of Shares Outstanding of 9273106 and a Short% of Float of 3.83.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
